Form 4: TFS Financial CORP Officer Cathy W. Zbanek Reports Transaction
SEC Form 4
Cathy W. Zbanek, Chief Synergy Officer of TFS Financial CORP, reports a transaction involving the sale of 15,000 shares of common stock at $13.46 per share on May 7, 2025, along with details of restricted stock units, performance share units, and employee stock options.
Summary
- Cathy W. Zbanek, Chief Synergy Officer of TFS Financial CORP [TFSL], filed a Form 4 on May 12, 2025.
- The report details a transaction on May 7, 2025, where 15,000 shares of common stock were disposed of at a price of $13.46 per share.
- Following the transaction, Zbanek directly owns 73,197 shares of common stock.
- Zbanek also indirectly owns 13,760 shares through an ESOP and 5,328 shares through a 401(k).
- The report also details holdings of restricted stock units (RSUs) and performance share units (PSUs) which represent a contingent right to receive one share of TFS Financial Corporation common stock.
- Zbanek holds 15,900 RSUs granted on December 19, 2024, vesting in three equal annual installments beginning December 10, 2025.
- She also holds 18,990 PSUs, representing the final determination of a December 15, 2022 award based on performance results during the two fiscal years ended September 30, 2024, vesting on December 10, 2025.
- Additionally, Zbanek holds 9,467 RSUs granted on March 4, 2024, vesting in three equal annual installments beginning December 10, 2024, and 4,667 RSUs granted on December 15, 2022, vesting in three equal annual installments beginning December 10, 2023.
- The report also lists employee stock options with varying exercise prices and expiration dates.
- These include options to buy 187,500 shares at $14.74 (expiring 01/05/2028), 108,300 shares at $14.81 (expiring 05/28/2025), 79,400 shares at $19.31 (expiring 12/15/2026), and 49,200 shares at $19.06 (expiring 12/17/2025).
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing an insider transaction. The sale of shares could be seen as slightly negative, but without further context, it's difficult to draw strong conclusions.
Negatives
- The sale of 15,000 shares by an officer could be perceived negatively by investors.
Risks
- Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is not always the case.
- The vesting of RSUs and PSUs is subject to continued employment and, in the case of PSUs, the achievement of performance targets.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's stock. Monitoring these filings can offer insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Comparing the vesting schedules and terms of the stock options and restricted stock units to those of executives at peer financial institutions would provide a benchmark for assessing the competitiveness of TFS Financial CORP's compensation practices.
- Analyzing the frequency and size of insider transactions at comparable companies can help determine whether the reported sale is an isolated event or part of a broader trend.
Stakeholder Impact
- Shareholders may be interested in the insider's perspective on the company's stock, as reflected in their trading activity.
- Employees holding company stock or options may be affected by any potential price movements resulting from insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/28/2015 | Grant date of 108,300 stock options at $14.81, vesting in five equal annual installments beginning May 28, 2016. |
| 12/15/2015 | Grant date of 49,200 stock options at $19.06, vesting in three equal annual installments beginning December 10, 2016. |
| 12/15/2016 | Grant date of 79,400 stock options at $19.31, vesting in three equal annual installments beginning December 10, 2017. |
| 01/08/2018 | Report date of a grant of 187,500 stock options at $14.74, vesting in three equal annual installments beginning December 10, 2018. |
| 12/15/2022 | Grant date of 14,000 Restricted Stock Units (RSUs), vesting in three equal annual installments beginning December 10, 2023, and target award of 21,000 Performance Share Units (PSUs). |
| 03/04/2024 | Grant date of 14,200 Restricted Stock Units (RSUs), vesting in three equal annual installments beginning December 10, 2024. |
| 09/30/2024 | End of the two fiscal year period for performance results related to the December 15, 2022 PSU award. |
| 11/21/2024 | Achievement of 90.0% performance level on the target award of 21,000 PSUs, resulting in a total earned award of 18,990 shares. |
| 12/19/2024 | Grant date of 15,900 Restricted Stock Units (RSUs), vesting in three equal annual installments beginning December 10, 2025. |
| 05/07/2025 | Transaction date: Sale of 15,000 shares of common stock at $13.46 per share. |
| 05/12/2025 | Date of Form 4 filing. |
| 05/28/2025 | Expiration date of employee stock options to buy 108,300 shares at $14.81. |
| 12/10/2025 | Vesting date for 18,990 Performance Share Units (PSUs) and first vesting installment of 15,900 Restricted Stock Units (RSUs). |
| 12/17/2025 | Expiration date of employee stock options to buy 49,200 shares at $19.06. |
| 12/15/2026 | Expiration date of employee stock options to buy 79,400 shares at $19.31. |
| 01/05/2028 | Expiration date of employee stock options to buy 187,500 shares at $14.74. |
Keywords
Form 4, insider trading, stock options, restricted stock units, performance share units, TFS Financial CORP, TFSL, Zbanek, Chief Synergy Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.